Discover how Dr. Akil Merchant and his team at Cedars-Sinai Medical Center are advancing biomarker-based cancer treatment using Lunaphore’s COMET™ platform.
In his latest video, Dr. Merchant shares how his lab optimized an 82-marker immuno-metabolic panel with COMET™, highlighting how automation, consistency, and reproducibility are redefining standards in translational research.
Deep spatial insights into the tumor microenvironment
Researchers at the University of Alabama at Birmingham used a 46-plex COMET™ panel to study pancreatic ductal adenocarcinoma (PDAC) in mice.
Their findings revealed heterogeneity in immune composition and spatial organization between pancreatic and liver tumors—key to understanding immune escape and infiltration mechanisms.
COMET™: the only fully automated, hyperplex platform
COMET™ delivers scalability, reproducibility, and automation without antibody conjugation or barcoding.
This breakthrough enables high-throughput spatial mapping and helps uncover cellular interactions that drive disease progression and therapeutic response.
Learn more
Have questions about COMET™ technology?
Our team of scientists is ready to help.
📩 Request more information →